Cargando…

Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients

AIMS/INTRODUCTION: Cardiovascular autonomic neuropathy (CAN) is a predictor of cardiovascular disease and mortality. Cardiovascular reflex tests (CARTs) are the gold standard for the diagnosis of CAN, but might not be feasible in large research cohorts or in clinical care. We investigated whether me...

Descripción completa

Detalles Bibliográficos
Autores principales: Pop‐Busui, Rodica, Backlund, Jye‐Yu C, Bebu, Ionut, Braffett, Barbara H, Lorenzi, Gayle, White, Neil H, Lachin, John M, Soliman, Elsayed Z
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756321/
https://www.ncbi.nlm.nih.gov/pubmed/34309223
http://dx.doi.org/10.1111/jdi.13635
_version_ 1784632546944876544
author Pop‐Busui, Rodica
Backlund, Jye‐Yu C
Bebu, Ionut
Braffett, Barbara H
Lorenzi, Gayle
White, Neil H
Lachin, John M
Soliman, Elsayed Z
author_facet Pop‐Busui, Rodica
Backlund, Jye‐Yu C
Bebu, Ionut
Braffett, Barbara H
Lorenzi, Gayle
White, Neil H
Lachin, John M
Soliman, Elsayed Z
author_sort Pop‐Busui, Rodica
collection PubMed
description AIMS/INTRODUCTION: Cardiovascular autonomic neuropathy (CAN) is a predictor of cardiovascular disease and mortality. Cardiovascular reflex tests (CARTs) are the gold standard for the diagnosis of CAN, but might not be feasible in large research cohorts or in clinical care. We investigated whether measures of heart rate variability obtained from standard electrocardiogram (ECG) recordings provide a reliable measure of CAN. MATERIALS AND METHODS: Standardized CARTs (R‐R response to paced breathing, Valsalva, postural changes) and digitized 12‐lead resting ECGs were obtained concomitantly in Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications participants (n = 311). Standard deviation of normally conducted R‐R intervals (SDNN) and the root mean square of successive differences between normal‐to‐normal R‐R intervals (rMSSD) were measured from ECG. Sensitivity, specificity, probability of correct classification and Kappa statistics evaluated the agreement between ECG‐derived CAN and CARTs‐defined CAN. RESULTS: Participants with CARTs‐defined CAN had significantly lower SDNN and rMSSD compared with those without CAN (P < 0.001). The optimal cut‐off points of ECG‐derived CAN were <17.13 and <24.94 ms for SDNN and rMSSD, respectively. SDNN plays a dominant role in defining CAN, with an area under the curve of 0.73, indicating fair test performance. The Kappa statistic for SDNN was 0.41 (95% confidence interval 0.30–0.51) for the optimal cut‐off point, showing fair agreement with CARTs‐defined CAN. Combining SDNN and rMSSD optimal cut‐off points does not provide additional predictive power for CAN. CONCLUSIONS: These analyses are the first to show the agreement between indices of heart rate variability derived from ECGs and the gold standard CARTs, thus supporting potential use as a measure of CAN in clinical research and clinical care.
format Online
Article
Text
id pubmed-8756321
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-87563212022-01-19 Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients Pop‐Busui, Rodica Backlund, Jye‐Yu C Bebu, Ionut Braffett, Barbara H Lorenzi, Gayle White, Neil H Lachin, John M Soliman, Elsayed Z J Diabetes Investig Articles AIMS/INTRODUCTION: Cardiovascular autonomic neuropathy (CAN) is a predictor of cardiovascular disease and mortality. Cardiovascular reflex tests (CARTs) are the gold standard for the diagnosis of CAN, but might not be feasible in large research cohorts or in clinical care. We investigated whether measures of heart rate variability obtained from standard electrocardiogram (ECG) recordings provide a reliable measure of CAN. MATERIALS AND METHODS: Standardized CARTs (R‐R response to paced breathing, Valsalva, postural changes) and digitized 12‐lead resting ECGs were obtained concomitantly in Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications participants (n = 311). Standard deviation of normally conducted R‐R intervals (SDNN) and the root mean square of successive differences between normal‐to‐normal R‐R intervals (rMSSD) were measured from ECG. Sensitivity, specificity, probability of correct classification and Kappa statistics evaluated the agreement between ECG‐derived CAN and CARTs‐defined CAN. RESULTS: Participants with CARTs‐defined CAN had significantly lower SDNN and rMSSD compared with those without CAN (P < 0.001). The optimal cut‐off points of ECG‐derived CAN were <17.13 and <24.94 ms for SDNN and rMSSD, respectively. SDNN plays a dominant role in defining CAN, with an area under the curve of 0.73, indicating fair test performance. The Kappa statistic for SDNN was 0.41 (95% confidence interval 0.30–0.51) for the optimal cut‐off point, showing fair agreement with CARTs‐defined CAN. Combining SDNN and rMSSD optimal cut‐off points does not provide additional predictive power for CAN. CONCLUSIONS: These analyses are the first to show the agreement between indices of heart rate variability derived from ECGs and the gold standard CARTs, thus supporting potential use as a measure of CAN in clinical research and clinical care. John Wiley and Sons Inc. 2021-08-14 2022-01 /pmc/articles/PMC8756321/ /pubmed/34309223 http://dx.doi.org/10.1111/jdi.13635 Text en © 2021 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Articles
Pop‐Busui, Rodica
Backlund, Jye‐Yu C
Bebu, Ionut
Braffett, Barbara H
Lorenzi, Gayle
White, Neil H
Lachin, John M
Soliman, Elsayed Z
Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients
title Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients
title_full Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients
title_fullStr Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients
title_full_unstemmed Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients
title_short Utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients
title_sort utility of using electrocardiogram measures of heart rate variability as a measure of cardiovascular autonomic neuropathy in type 1 diabetes patients
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756321/
https://www.ncbi.nlm.nih.gov/pubmed/34309223
http://dx.doi.org/10.1111/jdi.13635
work_keys_str_mv AT popbusuirodica utilityofusingelectrocardiogrammeasuresofheartratevariabilityasameasureofcardiovascularautonomicneuropathyintype1diabetespatients
AT backlundjyeyuc utilityofusingelectrocardiogrammeasuresofheartratevariabilityasameasureofcardiovascularautonomicneuropathyintype1diabetespatients
AT bebuionut utilityofusingelectrocardiogrammeasuresofheartratevariabilityasameasureofcardiovascularautonomicneuropathyintype1diabetespatients
AT braffettbarbarah utilityofusingelectrocardiogrammeasuresofheartratevariabilityasameasureofcardiovascularautonomicneuropathyintype1diabetespatients
AT lorenzigayle utilityofusingelectrocardiogrammeasuresofheartratevariabilityasameasureofcardiovascularautonomicneuropathyintype1diabetespatients
AT whiteneilh utilityofusingelectrocardiogrammeasuresofheartratevariabilityasameasureofcardiovascularautonomicneuropathyintype1diabetespatients
AT lachinjohnm utilityofusingelectrocardiogrammeasuresofheartratevariabilityasameasureofcardiovascularautonomicneuropathyintype1diabetespatients
AT solimanelsayedz utilityofusingelectrocardiogrammeasuresofheartratevariabilityasameasureofcardiovascularautonomicneuropathyintype1diabetespatients
AT utilityofusingelectrocardiogrammeasuresofheartratevariabilityasameasureofcardiovascularautonomicneuropathyintype1diabetespatients